Ömer KUTLU, Zeynal DOĞAN, Hatice Meral EKŞİOĞLU, Murat KEKİLLİ

Relationship between helicobacter pylori infection and pityriasis versicolor: can helicobacter pylori infection be a new etiologic factor for pityriasis versicolor?

Background/aim: H. pylori has been found to be related to certain dermatological diseases. However, there is no data as yet to proposean association between H. pylori and pityriasis versicolor. In this study, we aimed to evaluate the association between H. pylori andpityriasis versicolor.Materials and methods: This was a prospective study performed in the Gastroenterology and Dermatology and Venereologydepartments of the Health Sciences University, Ankara Training and Research Centre. A total of 57 consecutive patients (27 pityriasisversicolor, 30 telogen effluvium) were enrolled from the Department of Dermatology and Venereology. All patients were screened forH. pylori IgG and CagA. In addition, urea breath test was carried out to detect the existence of H. pylori infection.Results: There were significantly higher rates of H. pylori positivity, H. pylori IgG in serum in the pityriasis versicolor group comparedto the telogen effluvium group (P < 0.05). In addition, the number of patients with dyspeptic complaints was higher in the pityriasisversicolor group than in the telogen effluvium group. The odds ratio for dyspepsia, H. pylori positivity, and H. pylori IgG were 2.48,1.67, and 1.78, respectively.Conclusion: In this study, we found a statistically significant relationship between H. pylori infection and pityriasis versicolor. Therefore,H. pylori eradication could be considered in recurrent pityriasis versicolor patients with dyspepsia. New studies are required to clarifythe effect of eradication treatment on the clinical course of pityriasis versicolor.

PDF

___

1. Pormohammad A, Ghotasleou R, Leylabadlo HM, Nasiri MJ, Dabiri H et al. Risk of gastric cancer in association with Helicobacter pylori different virulence factors: A systematic review and meta-analysis. Microbial Pathogenesis 2018; 118: 214-219. doi: 10.1016/j.micpath.2018.03.004
2. Doğan Z, Özdemir P, Ekşioğlu M, Filik L. Relationship between helicobacter pylori infection and vitiligo: A prospective study. American Journal of Clinical Dermatology 2014; 15 (5): 457- 462. doi: 10.1007/s40257-014-0087-3
3. Liwei S, Kang E, Jie L, Jian Y, Chunyu H. Correlations between anti-mast cell autoantibodies and chronic ıdiopathic urticaria. Annals of Dermatology 2014; 26 (2): 145–149. doi: 10.5021/ ad.2014.26.2.145
4. Maeda M, Makimura K, Yamaguchi H. Pityriasis versicolor rubra. European Journal of Dermatology 2002; 12 (2): 160-164.
5. Ingordo V, Naldi L, Colecchia B, Licci N. Prevalence of pityriasis versicolor in young Italian sailors. British Journal of Dermatology 2003; 149 (6): 1270- 1272. doi:10.1111/j.1365- 2133.2003.05549.x
6. Galadari IH, Sheriff MO. The role of helicobacter pylori in urticaria and atopic dermatitis. Skinmed Journal 2006; 5 (4): 172-176. doi: 10.1111/j.1540-9740.2006.04646.x
7. Realdi G, Dore MP, Fastame L. Extradigestive manifestations of helicobacter pylori infection (fact and fiction). Digestive Diseases and Sciences 1999; 44 (2): 229-236. doi: 10.1023/a:1026677728175
8. Magen E, Mishal J, Schlesinger M, Scharf S. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter 2007; 12 (5): 567-571. doi: 10.1111/j.1523- 5378.2007.00522.x
9. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004; 103 (3): 890-896. doi: 10.1182/blood-2003-03-0900
10. Suvajdžić N, Stanković B, Artiko V, Cvejic T, Bulat V et al. Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura. Platelets 2006; 17 (4): 227-230. doi: 10.1080/09537100500462487
11. Magen E, Mishal J. Possible benefit from treatment of helicobacter pylori in antihistamine‐resistant chronic urticaria. Clinical and Experimental Dermatology 2013; 38 (1): 7-12. doi:10.1111/j.1365-2230.2012.04467.x
12. Avcı O, Ellidokuz E, Şimşek I, Büyükgebiz B, Güneş AT. Helicobacter pylori and Behçet’s disease. Dermatology 1999; 199 (2): 140-143. doi: 10.1159/000018221
13. Effendy I, Lecha M, de Feuilhade CM, Di CN, Baran R. Epidemiology and clinical classification of onychomycosis. Journal of the European Academy of Dermatology and Venereology 2005; 19: 8-12. doi: 10.1111/j.1468- 3083.2005.01281.x
14. Rezabek GH, Friedman AD. Superficial fungal infections of the skin. Drugs 1992; 43 (5): 674-682. doi:10.2165/00003495- 199243050-00004
15. Kelly BP. Superficial fungal infections. Pediatrics in Review 2012; 33 (4): e22-37. doi: 10.1542/pir.33-4-e22
16. Hudson A, Sturgeon A, Peiris A. Tinea versicolor. Journal of the American Medical Association. 2018; 320 (13): 1396. doi: 10.1001/jama.2018.12429
17. Das S, Goyal R, Bhattacharya S. Laboratory‐based epidemiological study of superficial fungal infections. Journal of Dermatology 2007; 34 (4): 248-253. doi: 10.1111/j.1346- 8138.2007.00262.x
18. Güleç AT, Demirbilek M, Seçkin D, Can F, Saray Y et al. Superficial fungal infections in 102 renal transplant recipients: A case-control study. Journal of the American Academy of Dermatology 2003; 49 (2): 187-192. doi: 10.1067/s0190- 9622(03)00861-2
19. Mendez-Tovar LJ. Pathogenesis of dermatophytosis and tinea versicolor. Clinical Dermatology 2010; 28 (2): 185-188. doi: 10.1016/j.clindermatol.2009.12.015
20. Díaz P, Valenzuela Valderrama M, Bravo J, Quest AFG. Helicobacter pylori and gastric cancer: Adaptive cellular mechanisms involved in disease progression. Frontiers in Microbiology 2018; 9: 5. doi: 10.3389/fmicb.2018.00005
21. Algood HMS, Cover TL. Helicobacter pylori persistence: An overview of interactions between H. pylori and host immune defenses. Clinical Microbiology Reviews 2006; 19 (4): 597-613. doi:10.1128/CMR.00006-06
22. Hasni S, Ippolito A, Illei G. Helicobacter pylori and autoimmune diseases. Oral Diseases 2011; 17 (3): 621-627. doi: 10.1111/j.1601-0825.2011.01796.x
23. Shi W-J, Liu W, Zhou XY, Ye F, Zhang GX. Associations of helicobacter pylori infection and cytotoxin-associated gene a status with autoimmune thyroid diseases: a meta-analysis. Thyroid 2013; 23 (10): 1294-1300. doi: 10.1089/thy.2012.0630
24. Smith S, Boyle B, Brennan D, Buckley M, Crotty P et al. The Irish Helicobacter pylori working group consensus for the diagnosis and treatment of H.pylori infection in adult patients in Ireland. European Journal of Gastroenterology & Hepatology 2017; 29 (5): 552-559. doi: 10.1097/MEG. 0000000000000822
25. A Özden, Bozdayi G, Özkan M, Köse KS. Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years. Turkish Journal of Gastroenterology 2004; 15 (3): 156-158.